COVID-19 At-Home Rapid Self Test, Results in 15 Minutes (FDA EUA Authorized), Non-invasive Nasal Swab, Easy to Use & No Discomfort (2-PACK)

AVAILABLE IN STOCK NOW! SHIPS NEXT DAY! SHIPS FROM: 2421 S SUSAN ST. SANTA ANA CA 92704 A PROUD USA COMPANY We have teamed up with manufacturers to offer FDA Authorized At-Home Rapid Self Test for the novel coronavirus, SARS-CoV-2, the virus that causes COVID-19. Included in the Package: 2 Complete Set of COVID-19 of Antigen Rapid Tests. Each of the two single-use test kits comes with everything needed to conduct a COVID-19 test. Non-Invasive At Home Test – FDA Authorized, Easy, Convenient, and Fast This test kit can be stored at room temperatures. Ships the next day. In Stock. (USPS delays may occur out of our own reach due to COVID-19, please see your local USPS announcements) Quick in-home testing takes away the worry of developing symptoms. Back to school, back to the office, or just back from travel or public gatherings, a rapid,15-minute, self-test is waiting at home for when you get back. The COVID-19 Antigen Rapid Test is a lateral flow assay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2. FDA Authorized 15-Minute Self-Test: Get instant COVID test results in 15 minutes! COVID-19 Antigen Rapid Test is the simplest way to detect SARS-CoV-2 nucleocapsid protein antigen. It only takes 4 steps and 15 minutes to complete the test. The test is also non-invasive. You won't need to collect a sample from deep in your nasal cavity to get accurate results. Easy to Use: Test can be done by inserting 1/2 to 3/4 inch of a simple non-invasive nasal swab. Step-by-step instructional videos are available in our app (App is optional). Its compact size makes it easy to store it away or take it with you in a travel bag. New variants have shown that anyone can be vulnerable to COVID-19 even if they are vaccinated or young. With COVID-19 Antigen Rapid Test, you can test yourself after being out in public. Early and regular testing helps you better care for yourself and protects your friends, family, and community members from potential exposure. COVID-19 Antigen Rapid Test app is available for iOS or Android phones: The app contains specific step-by-step video instructions to complete the test. Based on the clinical trial results, where the test was compared to an FDA-authorized molecular SARS-CoV-2 test, the test correctly identified 94.3% of positive specimens and 98.1% of negative specimens. Manage Group Testing Via Mobile App: The Self-Test app allows the administrator of a small group to monitor and track the group members’ test results as needed at school, work or an event. Click here for How to use the COVID-19 Antigen Rapid Test Legal Disclaimer The COVID-19 Antigen Rapid Test is a lateral flow assay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2. This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 15 years or older with symptoms of COVID-19 within the first seven days of symptom onset. This test is also authorized for non-prescription home use with adult-collected nasal swab samples from individuals aged 2 years or older with symptoms of COVID-19 within the first seven days of symptom onset. This test is also authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 15 years or older, or adult collected anterior nasal swab samples from individuals aged 2 years or older, with or without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests. This COVID-19 Antigen Home Test Kit has not been FDA cleared or approved. It has been authorized by the FDA under an Emergency Use Authorization. It has been authorized only for the detection of proteins from SARS-CoV-2, not for any other viruses or pathogens, and is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. 360bbb-3(b)(1), unless the declaration is terminated, or the authorization is revoked sooner. Click here for COVID-19 Test Kit FDA EUA Letter Click here for COVID-19 Test Kit FDA EUA Letter Click here for COVID-19 Test Kit FDA EUA Letter Click here for COVID-19 Test Kit FDA EUA Letter Click here for COVID-19 Test Kit FDA EUA Letter Click here for COVID-19 Test Kit FDA EUA Letter